BARCLAYS PLC - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 126 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,215
+1477.9%
254,231
+1296.0%
0.00%
Q2 2023$77
-85.7%
18,211
-82.0%
0.00%
Q1 2023$538
-28.6%
101,192
-15.7%
0.00%
Q4 2022$754
-99.9%
120,091
+44.0%
0.00%
-100.0%
Q3 2022$880,000
+5766.7%
83,401
+2978.7%
0.00%
Q2 2022$15,000
-80.5%
2,709
-67.6%
0.00%
Q1 2022$77,0008,3690.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$10,174,0006.39%
72 Investment Holdings, LLC 474,067$7,154,0006.35%
Velan Capital Investment Management LP 210,695$3,179,0002.47%
PFM Health Sciences, LP 4,092,309$59,418,0002.02%
Monashee Investment Management LLC 504,377$7,611,0001.88%
CloudAlpha Capital Management Limited/Hong Kong 415,000$6,262,0001.49%
Avidity Partners Management LP 2,674,067$40,352,0000.86%
Rokos Capital Management LLP 570,359$8,604,0000.52%
Green Alpha Advisors, LLC 35,592$537,0000.36%
Tekla Capital Management LLC 699,377$9,875,0000.32%
View complete list of CARIBOU BIOSCIENCES INC shareholders